Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00500487 · ClinicalTrials.gov registry record · Phase 1
Therapeutic Schools: Affect Management and HIV Prevention
A Phase 1 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 420
- Enrollment target
NCT00500487: Completed Phase 1 study, sponsored by Rhode Island Hospital.
NCT00500487 is a Phase 1 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 420 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (600% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00500487, a Phase 1 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 420 participants
- Enrollment target
Study Summary
Adolescents are at risk for HIV because of sexual and drug behavior intiated during this developmental period. Those with psychological distress are less likely than their peers to benefit from frequently used skills-based interventions. It appears that emotional lability during sexual situations disrupts skills learned. This project will implement and evaluate interventions for adolescents with psychiatric disorders who are in therapeutic school settings. Affect management and skills-based interventions will be compared to a didactic standard of care condition to determine which intervention best reduces risk behavior among adolescents with psychiatric disorders in therapeutic school settings.
Interventions
- BEHAVIORAL General Health Promotion
- BEHAVIORAL Affect Management
- BEHAVIORAL HIV Prevention Skills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2003-04 |
| Est. Completion | 2010-06 |
| Phase | Phase 1 |
What the finished NCT00500487 record still lists
NCT00500487 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (600% higher).
The record links to 0 conditions, and to 3 interventions - of which General Health Promotion is the first listed.
NCT00500487 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00500487 about?
NCT00500487 is a clinical study titled "Therapeutic Schools: Affect Management and HIV Prevention". Adolescents are at risk for HIV because of sexual and drug behavior intiated during this developmental period. Those with psychological distress are less likely than their peers to benefit from frequently used skills-based interventions. It appears that emotional lability during sexual situations di...
What is the current status of trial NCT00500487?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 420 participants. The study started on 2003-04. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00500487?
The interventions under investigation include: General Health Promotion (BEHAVIORAL), Affect Management (BEHAVIORAL), HIV Prevention Skills (BEHAVIORAL).
Who is sponsoring clinical trial NCT00500487?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00500487's enrollment target sits among peer trials
420 66th of 2000 higher than 1,932 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia